NCT07683390

Brief Summary

Patients with suspected DD who met the Rome IV criteria were divided into the DD group and other types of constipation groups. The differences between the two groups were analyzed to explore the precise diagnostic scheme for DD.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
164

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 21, 2023

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2026

Completed
16 days until next milestone

First Submitted

Initial submission to the registry

June 16, 2026

Completed
20 days until next milestone

First Posted

Study publicly available on registry

July 6, 2026

Completed
Last Updated

July 6, 2026

Status Verified

July 1, 2023

Enrollment Period

2.9 years

First QC Date

June 16, 2026

Last Update Submit

June 28, 2026

Conditions

Keywords

Dyssynergic defecationPuborectalis syndromeDefecographyHigh-resolution anorectal manometryPelvic Floor Ultrasound

Outcome Measures

Primary Outcomes (1)

  • Rectal emptying rate,(%)

    Rectal emptying rate is defined as the reduction in rectal area from pre-evacuation to post-evacuation, expressed as a percentage of the pre-evacuation area, as assessed by defecography.

    Baseline assessment

Secondary Outcomes (21)

  • Obstructed Defecation Syndrome score,(ODS score)

    Baseline assessment

  • Cleveland Clinic Constipation Score,(CCCS)

    Baseline assessment

  • Patient Assessment of Constipation Quality of Life total score,(PAC-QOL score)

    Baseline assessment

  • Self-Rating Anxiety Scale score,(SAS score)

    Baseline assessment

  • Bristol Stool Form Scale score

    Baseline assessment

  • +16 more secondary outcomes

Study Arms (1)

patients with suspected PRS-related DD

Other: Analysis of inter-group differences

Interventions

Analysis of inter-group differences

patients with suspected PRS-related DD

Eligibility Criteria

Age16 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

patients with suspected PRS-related DD

You may qualify if:

  • Age ranges from 16 to 85 years old.
  • Constipation patients should meet the Rome Ⅳ criteria for chronic constipation (must include two or more of the following: ① At least 25% of bowel movements are strenuous; ② At least 25% of bowel movements are lumpy or hard stools; ③ At least 25% of bowel movements are accompanied by a sense of incomplete evacuation; ④ At least 25% of bowel movements are associated with a feeling of anorectal obstruction or blockage; ⑤ At least 25% of bowel movements require manual assistance; ⑥ Fewer than 3 bowel movements per week). The healthy volunteer group has no above - mentioned constipation symptoms.
  • Participants should be able to understand and complete relevant questionnaires.
  • Participants should be willing to follow the research protocol and sign the informed consent form.

You may not qualify if:

  • Pregnant women and lactating women
  • Suffering from gastrointestinal and other malignant tumors
  • Suffering from diseases such as diabetes and Parkinson's disease
  • Currently participating in other clinical trials

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Army Medical Center (Daping Hospital)

Yuzhong, Chongqing Municipality, 400042, China

Location

Study Officials

  • Weidong Tong, MD

    Army Medical Center (Daping Hospital)

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director

Study Record Dates

First Submitted

June 16, 2026

First Posted

July 6, 2026

Study Start

July 21, 2023

Primary Completion

May 31, 2026

Study Completion

May 31, 2026

Last Updated

July 6, 2026

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will not share

Locations